Haemonetics Corporation

Historical 13F Holders

Symbol
HAE
CUSIP
405024100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 405024100 since 12/18/2024, newest first.

Filer % of Class Filed
AQR Capital Management, LLC 13G/A Amendment 1
4.99% 8/12/2026
Event 6/30/2026
North Peak Capital Management, LLC 13G/A Amendment 1
0% 5/13/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.3% 4/30/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 5.6% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 15 0% 3/27/2026
Event 3/13/2026
North Peak Capital Management, LLC 13G
5.1% 3/3/2026
Event 2/24/2026
AQR Capital Management, LLC 13G
6.8% 2/13/2026
Event 12/31/2025
Wellington Management Group LLP 13G/A Amendment 6
4.6% 8/12/2025
Event 6/30/2025
T. Rowe Price Investment Management, Inc. 13G/A Amendment 1 4.4% 5/14/2025
Event 3/31/2025
Wellington Management Group LLP 13G/A Amendment 5
5.4% 5/12/2025
Event 3/31/2025
Capital Research Global Investors 13G/A Amendment 4 3.1% 4/4/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 21.1 k $2.23 M
2026 Q2 345 53.7 M $3.77 B
2026 Q1 333 47.6 M $2.68 B
2025 Q4 353 51.7 M $4.15 B
2025 Q3 321 51.6 M $2.51 B
2025 Q2 321 55.6 M $4.13 B
2025 Q1 339 54.5 M $3.45 B
2024 Q4 338 56.8 M $4.41 B
2024 Q3 329 56.3 M $4.52 B
2024 Q2 334 56.4 M $4.67 B
2024 Q1 312 52.0 M $4.44 B
2023 Q4 316 51.4 M $4.40 B
2023 Q3 313 50.8 M $4.55 B
2023 Q2 312 50.6 M $4.30 B
2023 Q1 322 50.9 M $4.19 B
2022 Q4 312 52.1 M $4.10 B
2022 Q3 284 51.8 M $3.84 B
2022 Q2 252 52.1 M $3.39 B
2022 Q1 252 51.6 M $3.26 B
2021 Q4 277 50.2 M $2.66 B
2021 Q3 265 50.7 M $3.58 B
2021 Q2 276 50.7 M $3.38 B
2021 Q1 309 50.0 M $5.55 B
2020 Q4 304 51.4 M $6.10 B
2020 Q3 282 49.5 M $4.32 B
2020 Q2 306 49.6 M $4.44 B
2020 Q1 283 50.7 M $5.05 B
2019 Q4 306 50.7 M $5.83 B
2019 Q3 287 49.8 M $6.28 B
2019 Q2 273 51.6 M $6.21 B
2019 Q1 274 51.4 M $4.50 B
2018 Q4 288 51.5 M $5.15 B
2018 Q3 306 53.9 M $6.18 B
2018 Q2 302 51.3 M $4.60 B
2018 Q1 268 53.7 M $3.93 B
2017 Q4 252 53.6 M $3.12 B
2017 Q3 208 54.8 M $2.46 B
2017 Q2 198 55.5 M $2.19 B
2017 Q1 183 54.7 M $2.22 B
2016 Q4 201 53.1 M $2.13 B
2016 Q3 183 51.8 M $1.88 B
2016 Q2 182 53.7 M $1.56 B
2016 Q1 173 51.3 M $1.79 B
2015 Q4 168 51.7 M $1.67 B
2015 Q3 173 52.1 M $1.68 B
2015 Q2 182 53.4 M $2.21 B
2015 Q1 173 53.8 M $2.41 B
2014 Q4 177 54.7 M $2.05 B
2014 Q3 174 53.1 M $1.85 B
2014 Q2 178 55.4 M $1.95 B
2014 Q1 198 54.2 M $1.77 B